Yin-Ching Chuang

Kaohsiung Chang Gung Memorial Hospital — Taiwan

Biochemistry, Genetics and Molecular Biology · Life Sciences

51h-index7.8kcitations228works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotic Resistance in Bacteria(112), Antibiotics Pharmacokinetics and Efficacy(54), Pneumonia and Respiratory Infections(33), Vibrio bacteria research studies(31), Antimicrobial Resistance in Staphylococcus(29)

Publications228 total

Comparative monocyte and T cell responses in DENV-exposed subjects from South-East Asia and DENV-naïve residents in Taiwan
Journal of Microbiology Immunology and Infection·2024· 1 citedOpen Access
Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment
European Journal of Clinical Microbiology & Infectious Diseases·2024· 1 citedOpen Access
Multicenter study on clinical outcomes and risk factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment
Research Square (Research Square)·2024Open Access
Efficacy of cefoperazone/sulbactam for ESBL-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bacteraemia and the factors associated with poor outcomes
Journal of Antimicrobial Chemotherapy·2024· 6 cited
Antimicrobial Susceptibility of E. coli Isolates from Intra-Abdominal Infections in the Asia-Pacific Region: Trends in Ciprofloxacin, Ceftriaxone, Cefepime, and Piperacillin/Tazobactam Susceptibility
Infection and Drug Resistance·2023· 3 citedOpen Access
The effect of Lactobacillus with prebiotics on KPC-2-producing Klebsiella pneumoniae
Frontiers in Microbiology·2022· 13 citedOpen Access
Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli Bacteremia
Infectious Diseases and Therapy·2022· 5 citedOpen Access
91. Gaps and Opportunities in Antimicrobial Stewardship Programs in Asia: A Survey of 10 Countries
Open Forum Infectious Diseases·2021· 1 citedOpen Access
Distribution of β-lactamases and emergence of carbapenemases co-occurring Enterobacterales isolates with high-level antibiotic resistance identified from patients with intra-abdominal infection in the Asia–Pacific region, 2015–2018
Journal of Microbiology Immunology and Infection·2021· 19 citedOpen Access
Molecular characteristics and <i>in vitro</i> effects of antimicrobial combinations on planktonic and biofilm forms of <i>Elizabethkingia anophelis</i>
Journal of Antimicrobial Chemotherapy·2021· 27 cited
UvrY is required for the full virulence of <i>Aeromonas dhakensis</i>
Figshare·2021Open Access
UvrY is required for the full virulence of <i>Aeromonas dhakensis</i>
Figshare·2021Open Access
Does Antimicrobial Therapy Affect Mortality of Patients with Carbapenem-Resistant Klebsiella pneumoniae Bacteriuria? A Nationwide Multicenter Study in Taiwan
Microorganisms·2020· 6 citedOpen Access
UvrY is required for the full virulence of <i>Aeromonas dhakensis</i>
Virulence·2020· 16 citedOpen Access
Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Critically Ill Patients
Antibiotics·2020· 5 citedOpen Access
In Vitro Synergy of Pongamia pinnata Extract in Combination with Antibiotics for Inhibiting and Killing Methicillin-Resistant Staphylococcus aureus
Antibiotics·2020· 4 citedOpen Access
Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae
Journal of Microbiology Immunology and Infection·2020· 49 citedOpen Access
In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
Antibiotics·2020· 16 citedOpen Access
Reply to Zhou and Wu, “Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam”
Antimicrobial Agents and Chemotherapy·2020Open Access
Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016
International Journal of Antimicrobial Agents·2020· 40 cited
page 1 of 12Next →

Frequent Co-authors

Wen‐Chien Ko(20), Hung-Jen Tang(10), Wen‐Liang Yu(7), Po‐Liang Lu(6), Yung-Ching Liu(6), Po‐Ren Hsueh(6), Hung-Jen Tang(6), Jann‐Tay Wang(6), Han Siong Toh(4), Yao-Shen Chen(4), Chang‐Phone Fung(4), L. Kristopher Siu(4), Jien-Wei Liu(4), Jiunn-Jong Wu(4), Feng‐Yee Chang(4), Chi-Chung Chen(4), Mei-Feng Lee(4), Kuo-Chen Cheng(3), Kwok-Woon Yu(3), Chi‐Chung Chen(3)